Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Journal of Perinatology volume 39, pages 1449–1461 (2019)Cite this article

Subjects

Abstract

The optimal management approach of the patent ductus arteriosus (PDA) in premature infants remains uncertain owing the lack of evidence for long-term benefits and the limited analyses of the complications of medical and surgical interventions to date. In recent years, devices suitable to plug the PDA of premature infants (including extremely low birthweight, <1000 g) have become available and several trials have demonstrated successful and safe transcatheter PDA closure (TCPC) in this population. Whether TCPC represents a paradigm shift in PDA management that will result in improved short- and long-term outcomes, less bronchopulmonary dysplasia, improved neurodevelopment, or better long term renal function remains to be seen. Careful rigorous study of the potential benefits of TCPC in this highly vulnerable population in the context of well-designed adequately powered trials is needed prior to widespread adoption of this approach.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Hundscheid T, van den Broek M, van der Lee R, de Boode WP. Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen. Pediatr Res. 2019;86:28–38.

    PubMed  Google Scholar 

  2. Gentile R, Stevenson G, Dooley T, Franklin D, Kawabori I, Pearlman A. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr. 1981;98:443–8.

    CAS  PubMed  Google Scholar 

  3. Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36:123–9.

    PubMed  PubMed Central  Google Scholar 

  4. Weber SC, Weiss K, Bührer C, Hansmann G, Koehne P, Sallmon H. Natural history of patent ductus arteriosus in very low birth weight infants after discharge. J Pediatr. 2015;167:1149–51.

    PubMed  Google Scholar 

  5. Herrman K, Bose C, Lewis K, Laughon M. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed. 2009;94:F48–50.

    CAS  PubMed  Google Scholar 

  6. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incid Nat Hist Circulation. 1971;43:323–32.

    CAS  Google Scholar 

  7. Lloyd TR, Beekman RH. Clinically silent patent ductus arteriosus. Am Heart J 1994;127:1664–5.

    CAS  PubMed  Google Scholar 

  8. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–82.

    PubMed  Google Scholar 

  9. El-Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J, Holzer R, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc. 2013;2:e000424.

    PubMed  PubMed Central  Google Scholar 

  10. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123:e138–44.

    PubMed  Google Scholar 

  11. Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics. 2010;125:1020–30.

    PubMed  Google Scholar 

  12. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005;40:184–8.

    CAS  PubMed  Google Scholar 

  13. Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99:F99–F104.

    PubMed  Google Scholar 

  14. Lipman B, Serwer GA, Brazy JE. Abnormal cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatrics. 1982;69:778–81.

    CAS  PubMed  Google Scholar 

  15. Bose CL, Laughon M. Treatment to prevent patency of the ductus arteriosus: beneficial or harmful? J Pediatr. 2006;148:713–4.

    PubMed  Google Scholar 

  16. Benitz WE. Committee of the fetus and newborn. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137:e20153730.

    Google Scholar 

  17. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92:F424–7.

    PubMed  PubMed Central  Google Scholar 

  18. Shepherd JL, Noori S. What is a hemodynamically significant PDA in preterm infants? Congenit Heart Dis. 2019;14:21–6.

    PubMed  Google Scholar 

  19. Jain A, Shah PS. Diagnosis, Evaluation, and Management of Patent Ductus Arteriosus in Preterm Neonates. JAMA Pediatr. 2015;169:863–72.

    PubMed  Google Scholar 

  20. Sathanandam S, Balduf K, Chilakala S, Washington K, Allen K, Knott-Craig C, et al. Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants. Catheter Cardiovasc Interv. 2019;93:89–96.

    PubMed  Google Scholar 

  21. Sathanandam S, Justino H, Waller BR, Radtke W, Qureshi AM. Initial clinical experience with the Medtronic Micro Vascular Plug™ in transcatheter occlusion of PDAs in extremely premature infants. Catheter Cardiovasc Interv. 2017;89:1051–8.

    PubMed  Google Scholar 

  22. Morville P, Akhavi A. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS. Catheter Cardiovasc Interv. 2017;90:612–7.

    PubMed  Google Scholar 

  23. Morville P, Douchin S, Bouvaist H, Dauphin C. Transcatheter occlusion of the patent ductus arteriosus in premature infants weighing less than 1200 g. Arch Dis Child Fetal Neonatal Ed. 2018;103:F198–F201.

    PubMed  Google Scholar 

  24. Zahn EM, Nevin P, Simmons C, Garg R. A novel technique for transcatheter patent ductus arteriosus closure in extremely preterm infants using commercially available technology. Catheter Cardiovasc Interv. 2015;85:240–8.

    PubMed  Google Scholar 

  25. Zahn EM, Peck D, Phillips A, Nevin P, Basaker K, Simmons C, et al. Transcatheter closure of patent ductus arteriosus in extremely premature newborns: early results and midterm follow-up. JACC Cardiovasc Interv. 2016;9:2429–37.

    PubMed  Google Scholar 

  26. Rodríguez Ogando A, Planelles Asensio I, de la Blanca ARS, Ballesteros Tejerizo F, Sánchez Luna M, Gil Jaurena JM, et al. Surgical ligation versus percutaneous closure of patent ductus arteriosus in very low-weight preterm infants: which are the real benefits of the percutaneous approach? Pediatr Cardiol. 2018;39:398–410.

    PubMed  Google Scholar 

  27. Wang-Giuffre EW, Breinholt JP. Novel use of the medtronic micro vascular plug for PDA closure in preterm infants. Catheter Cardiovasc Interv. 2017;89:1059–65.

    PubMed  Google Scholar 

  28. Bouayad A, Kajino H, Waleh N, Fouron JC, Andelfinger G, Varma DR, et al. Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus. Am J Physiol Heart Circ Physiol. 2001;280:H2342–9.

    CAS  PubMed  Google Scholar 

  29. Coceani F, Huhtanen D, Hamilton NC, Bishai I, Olley PM. Involvement of intramural prostaglandin E2 in prenatal patency of the lamb ductus arteriosus. Can J Physiol Pharmacol. 1986;64:737–44.

    CAS  PubMed  Google Scholar 

  30. Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, Chen YQ. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs: the role of gestation, oxygen tension, and vasa vasorum. Pediatr Res. 1998;43:633–44.

    CAS  PubMed  Google Scholar 

  31. Clyman RI, Chan CY, Mauray F, Chen YQ, Cox W, Seidner SR, et al. Permanent anatomic closure of the ductus arteriosus in newborn baboons: the roles of postnatal constriction, hypoxia, and gestation. Pediatr Res. 1999;45:19–29.

    CAS  PubMed  Google Scholar 

  32. Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate. 2006;89:330–5.

    PubMed  Google Scholar 

  33. Thorburn GD. The placenta, PGE2 and parturition. Early Hum Dev. 1992;29:63–73.

    CAS  PubMed  Google Scholar 

  34. Clyman RI, Mauray F, Roman C, Heymann MA, Payne B. Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2. J Pediatr. 1983;102:907–11.

    CAS  PubMed  Google Scholar 

  35. Clyman RI, Mauray F, Rudolph AM, Heymann MA. Age-dependent sensitivity of the lamb ductus arteriosus to indomethacin and prostaglandins. J Pediatr. 1980;96:94–8.

    CAS  PubMed  Google Scholar 

  36. Tsai MY, Einzig S. Prostaglandin catabolism in fetal and maternal tissues-a study of 15-hydroxyprostaglandin dehydrogenase and delta 13 reductase with specific assay methods. Prostaglandins Leukot Ess Fat Acids. 1989;38:25–30.

    CAS  Google Scholar 

  37. Kajino H, Goldbarg S, Roman C, Liu BM, Mauray F, Chen YQ, et al. Vasa vasorum hypoperfusion is responsible for medial hypoxia and anatomic remodeling in the newborn lamb ductus arteriosus. Pediatr Res. 2002;51:228–35.

    PubMed  Google Scholar 

  38. Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health. 1994;30:406–11.

    CAS  PubMed  Google Scholar 

  39. Evans N, Moorcraft J. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants. Arch Dis Child. 1992;67(10 Spec No):1169–73.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Alagarsamy S, Chhabra M, Gudavalli M, Nadroo AM, Sutija VG, Yugrakh D. Comparison of clinical criteria with echocardiographic findings in diagnosing PDA in preterm infants. J Perinat Med. 2005;33:161–4.

    PubMed  Google Scholar 

  41. Davis P, Turner-Gomes S, Cunningham K, Way C, Roberts R, Schmidt B. Precision and accuracy of clinical and radiological signs in premature infants at risk of patent ductus arteriosus. Arch Pediatr Adolesc Med. 1995;149:1136–41.

    CAS  PubMed  Google Scholar 

  42. Zonnenberg I, de Waal K. The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr. 2012;101:247–51.

    PubMed  Google Scholar 

  43. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr. 2011;100:231–5.

    CAS  PubMed  Google Scholar 

  44. Ramos FG, Rosenfeld CR, Roy L, Koch J, Ramaciotti C. Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates. J Perinatol. 2010;30:535–9.

    CAS  PubMed  Google Scholar 

  45. de Freitas Martins F, Ibarra Rios D, Resende MHF, Javed H, Weisz D, Jain A, et al. Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume. J Pediatr. 2018;202:50–5.e3.

    PubMed  Google Scholar 

  46. Evans N, Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed. 1995;72:F156–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Su BH, Watanabe T, Shimizu M, Yanagisawa M. Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed. 1997;77:F36–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Iyer P, Evans N. Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 1994;70:F112–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound? Semin Perinatol. 2012;36:114–22.

    PubMed  Google Scholar 

  50. El-Khuffash A, Molloy E. The use of N-terminal-Pro-BNP in preterm infants. Int J Pediatr. 2009;2009:175216.

    PubMed  PubMed Central  Google Scholar 

  51. Underwood MA, Milstein JM, Sherman MP. Near-infrared spectroscopy as a screening tool for patent ductus arteriosus in extremely low birth weight infants. Neonatology. 2007;91:134–9.

    PubMed  Google Scholar 

  52. Schwarz CE, Preusche A, Wolf M, Poets CF, Franz AR. Prospective observational study on assessing the hemodynamic relevance of patent ductus arteriosus with frequency domain near-infrared spectroscopy. BMC Pediatr. 2018;18:66.

    PubMed  PubMed Central  Google Scholar 

  53. Weisz DE, McNamara PJ, El-Khuffash A. Cardiac biomarkers and haemodynamically significant patent ductus arteriosus in preterm infants. Early Hum Dev. 2017;105:41–7.

    PubMed  Google Scholar 

  54. Broadhouse KM, Price AN, Durighel G, Cox DJ, Finnemore AE, Edwards AD, et al. Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI. NMR Biomed. 2013;26:1135–41.

    PubMed  Google Scholar 

  55. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010, CD000174.

  56. Sankar MN, Bhombal S, Benitz WE. PDA: To treat or not to treat. Congenit Heart Dis. 2019;14:46–51.

    PubMed  Google Scholar 

  57. Benitz WE, Committee on fetus and newborn AeAoP. Patent ductus arteriosus in preterm infants. Pediatrics. 2016;137:e20153730.

    Google Scholar 

  58. Liebowitz M, Clyman RI. Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes. J Pediatr. 2017;187:119–26.e1.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Coceani F, Olley PM, Bodach E. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2. Prostaglandins. 1975;9:299–308.

    CAS  PubMed  Google Scholar 

  60. Heymann MA, Rudolph AM. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res. 1976;38:418–22.

    CAS  PubMed  Google Scholar 

  61. Sharpe GL, Thalme B, Larsson KS. Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor. Prostaglandins. 1974;8:363–8.

    CAS  PubMed  Google Scholar 

  62. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med. 1976;295:526–9.

    CAS  PubMed  Google Scholar 

  63. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976;295:530–3.

    CAS  PubMed  Google Scholar 

  64. Patel J, Marks KA, Roberts I, Azzopardi D, Edwards AD. Ibuprofen treatment of patent ductus arteriosus. Lancet. 1995;346:255.

    CAS  PubMed  Google Scholar 

  65. Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 2000;343:674–81.

    PubMed  Google Scholar 

  66. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev. 2015, CD003481.

  67. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA. 2018;319:1221–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Irmesi R, Marcialis MA, Anker JV, Fanos V. Non-steroidal anti-inflammatory drugs (NSAIDs) in the management of patent ductus arteriosus (PDA) in preterm infants and variations in attitude in clinical practice: a flight around the world. Curr Med Chem. 2014;21:3132–52.

    CAS  PubMed  Google Scholar 

  69. Jobe AH. Drug pricing in pediatrics: the egregious example of indomethacin. Pediatrics 2007;119:1197–8.

    PubMed  Google Scholar 

  70. Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013;98:462–6.

    PubMed  Google Scholar 

  71. Terrin G, Conte F, Oncel MY, Scipione A, McNamara PJ, Simons S, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2016;101:F127–36.

    PubMed  Google Scholar 

  72. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2018;4:CD010061.

    PubMed  Google Scholar 

  73. Nemerofsky SL, Parravicini E, Bateman D, Kleinman C, Polin RA, Lorenz JM. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008;25:661–6.

    PubMed  Google Scholar 

  74. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117:1113–21.

    PubMed  Google Scholar 

  75. El-Mashad AE, El-Mahdy H, El Amrousy D, Elgendy M. Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates. Eur J Pediatr. 2017;176:233–40.

    CAS  PubMed  Google Scholar 

  76. Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S, Lindqvist J, et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol. 2019;39:599–607.

    PubMed  PubMed Central  Google Scholar 

  77. Clyman RI, Liebowitz M. Treatment and nontreatment of the patent ductus arteriosus: identifying their roles in neonatal morbidity. J Pediatr. 2017;189:13–7.

    PubMed  PubMed Central  Google Scholar 

  78. Hansson L, Lind T, Wiklund U, Öhlund I, Rydberg A. Fluid restriction negatively affects energy intake and growth in very low birth weight infants with haemodynamically significant patent ductus arteriosus. Acta Paediatr. 2019 (Epub ahead of print).

  79. Ong KK, Kennedy K, Castañeda-Gutiérrez E, Forsyth S, Godfrey KM, Koletzko B, et al. Postnatal growth in preterm infants and later health outcomes: a systematic review. Acta Paediatr. 2015;104:974–86.

    PubMed  PubMed Central  Google Scholar 

  80. Levitsky S, Fisher E, Vidyasagar D, Hastreiter AR, Bennett E, Raju TN, et al. Interruption of patent ductus arteriosus in premature infants with respiratory distress syndrome. Ann Thorac Surg. 1976;22:131–7.

    CAS  PubMed  Google Scholar 

  81. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93:647–51.

    CAS  PubMed  Google Scholar 

  82. Cassady G, Crouse DT, Kirklin JW, Strange MJ, Joiner CH, Godoy G, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 1989;320:1511–6.

    CAS  PubMed  Google Scholar 

  83. Mandhan PL, Samarakkody U, Brown S, Kukkady A, Maoate K, Blakelock R, et al. Comparison of suture ligation and clip application for the treatment of patent ductus arteriosus in preterm neonates. J Thorac Cardiovasc Surg. 2006;132:672–4.

    PubMed  Google Scholar 

  84. Georgeson KE, Robertson DJ. Minimally invasive surgery in the neonate: review of current evidence. Semin Perinatol. 2004;28:212–20.

    PubMed  Google Scholar 

  85. Laborde F, Noirhomme P, Karam J, Batisse A, Bourel P, Saint Maurice O. A new video-assisted thoracoscopic surgical technique for interruption of patient ductus arteriosus in infants and children. J Thorac Cardiovasc Surg. 1993;105:278–80.

    CAS  PubMed  Google Scholar 

  86. Hines MH, Raines KH, Payne RM, Covitz W, Cnota JF, Smith TE, et al. Video-assisted ductal ligation in premature infants. Ann Thorac Surg. 2003;76:1417–20. discussion 20.

    PubMed  Google Scholar 

  87. Lukish JR. Video-assisted thoracoscopic ligation of a patent ductus arteriosus in a very low-birth-weight infant using a novel retractor. J Pediatr Surg. 2009;44:1047–50.

    PubMed  Google Scholar 

  88. Noori S. Pros and cons of patent ductus arteriosus ligation: hemodynamic changes and other morbidities after patent ductus arteriosus ligation. Semin Perinatol. 2012;36:139–45.

    PubMed  Google Scholar 

  89. Moin F, Kennedy KA, Moya FR. Risk factors predicting vasopressor use after patent ductus arteriosus ligation. Am J Perinatol. 2003;20:313–20.

    PubMed  Google Scholar 

  90. Harting MT, Blakely ML, Cox CS, Lantin-Hermoso R, Andrassy RJ, Lally KP. Acute hemodynamic decompensation following patent ductus arteriosus ligation in premature infants. J Investig Surg. 2008;21:133–8.

    Google Scholar 

  91. Clyman RI, Wickremasinghe A, Merritt TA, Solomon T, McNamara P, Jain A, et al. Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones. J Pediatr. 2014;164:1449–55.e1.

    CAS  PubMed  PubMed Central  Google Scholar 

  92. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150:229–34, 34.e1.

    CAS  PubMed  Google Scholar 

  93. Mirea L, Sankaran K, Seshia M, Ohlsson A, Allen AC, Aziz K, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr. 2012;161:689–94.e1.

    PubMed  Google Scholar 

  94. Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133:e1024–46.

    PubMed  Google Scholar 

  95. Campbell M. Natural history of persistent ductus arteriosus. Br Heart J. 1968;30:4–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  96. Merritt TA, DiSessa TG, Feldman BH, Kirkpatrick SE, Gluck L, Friedman WF. Closure of the patent ductus arteriosus with ligation and indomethacin: a consecutive experience. J Pediatr. 1978;93:639–46.

    CAS  PubMed  Google Scholar 

  97. Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med. 1982;306:506–10.

    CAS  PubMed  Google Scholar 

  98. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30:241–52.

    CAS  PubMed  Google Scholar 

  99. Reese J, Scott TA, Patrick SW. Changing patterns of patent ductus arteriosus surgical ligation in the United States. Semin Perinatol. 2018;42:253–61.

    PubMed  PubMed Central  Google Scholar 

  100. Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units. J Pediatr. 2017;189:105–12.

    PubMed  Google Scholar 

  101. Lokku A, Mirea L, Lee SK, Shah PS, Network CN. Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol. 2017;34:441–50.

    PubMed  Google Scholar 

  102. Sathanandam S, Whiting S, Cunningham J, Zurakowski D, Apalodimas L, Waller BR, et al. Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: survey results among cardiologists and neonatologists. Congenit Heart Dis. 2019;14:6–14.

    PubMed  Google Scholar 

  103. Porstmann W, Wierny L, Warnke H. Closure of persistent ductus arteriosus without thoracotomy. Ger Med Mon. 1967;12:259–61.

    CAS  PubMed  Google Scholar 

  104. Moore JW, Vincent RN, Beekman RH, Benson L, Bergersen L, Holzer R, et al. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2014;64:2439–51.

    PubMed  Google Scholar 

  105. Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG, et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤ 6 kg. JACC Cardiovasc Interv. 2010;3:1295–9.

    PubMed  Google Scholar 

  106. Backes CH, Rivera BK, Bridge JA, Armstrong AK, Boe BA, Berman DP, et al. Percutaneous patent ductus arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics. 2017;139:e20162927.

    PubMed  Google Scholar 

  107. Backes CH, Cheatham SL, Deyo GM, Leopold S, Ball MK, Smith CV, et al. Percutaneous patent ductus arteriosus (PDA) closure in very preterm infants: feasibility and complications. J Am Heart Assoc. 2016;5:e002923.

    PubMed  PubMed Central  Google Scholar 

  108. Sathanandam S, Balduf K, Chilakala S, Washington K, Allen K, Knott-Craig C, et al. Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants. Catheter Cardiovasc Interv. 2019;93:89–96.

    PubMed  Google Scholar 

  109. Philip R, Waller BR, Agrawal V, Wright D, Arevalo A, Zurakowski D, et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Catheter Cardiovasc Interv. 2016;87:310–7.

    PubMed  Google Scholar 

  110. Krichenko A, Benson LN, Burrows P, Möes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989;63:877–80.

    CAS  PubMed  Google Scholar 

  111. Agrawal H, Waller BR, Surendan S, Sathanandam S. New patent ductus arteriosus closure devices and techniques. Interv Cardiol Clin. 2019;8:23–32.

    PubMed  Google Scholar 

  112. Bass JL, Wilson N. Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv. 2014;83:250–5.

    PubMed  Google Scholar 

  113. Baspinar O, Sahin DA, Sulu A, Irdem A, Gokaslan G, Sivasli E, et al. Transcatheter closure of patent ductus arteriosus in under 6 kg and premature infants. J Interv Cardiol. 2015;28:180–9.

    PubMed  Google Scholar 

  114. Rodríguez Ogando A, Ballesteros Tejerizo F, Blanco Bravo D, Sánchez Luna M, Zunzunegui Martínez JL. Transcatheter occlusion of patent ductus arteriosus in preterm infants weighing less than 2 kg with the amplatzer duct occluder II additional sizes device. Rev Esp Cardiol. 2018;71:865–6.

    PubMed  Google Scholar 

  115. Bentham J, Meur S, Hudsmith L, Archer N, Wilson N. Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv. 2011;77:409–15.

    PubMed  Google Scholar 

  116. McNamara PJ, Giesinger RE, Backes CH. Cardiac catheterisation for closure of patent ductus arteriosus. Lancet Child Adolesc Health. 2019;3:290–2.

    PubMed  Google Scholar 

Download references

Funding

The work has been supported by NIH grants HD096299 (PV) and HD072929 (SL).

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of California Davis, Sacramento, CA, USA

    P. Vali, S. Lakshminrusimha, A. Pelech, M. Underwood & F. Ing

Authors
  1. P. Vali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Lakshminrusimha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Pelech
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Underwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Ing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Vali.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vali, P., Lakshminrusimha, S., Pelech, A. et al. Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?. J Perinatol 39, 1449–1461 (2019). https://doi.org/10.1038/s41372-019-0506-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0506-7

This article is cited by

Search

Advanced search

Quick links